Phase 1 Pharmacokinetics of Intravenous Nexium in Children

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this research study is to evaluate how much of repeated once daily intravenous (IV, meaning through a vein) doses of esomeprazole gets into the bloodstream of hospitalized children aged 0-17 years old that require acid suppression therapy.
Epistemonikos ID: 3ce29c12d09eb97e1f26b94a2bc30812da1442fc
First added on: May 04, 2024